Emory neurologist named to HHS Alzheimer's disease advisory council

The U.S. Department of Health and Human Services (HHS) has appointed Emory neurologist Allan Levey, MD, PhD to serve on the Advisory Council on Alzheimer's Research, Care, and Services. He is one of six new members who will serve four-year terms beginning this month.

Levey is a professor and chair of the Department of Neurology at Emory University School of Medicine, and the Goizueta Foundation Endowed Chair for Alzheimer's Disease Research. He also serves as director of Emory's Alzheimer's Disease Research Center and has secondary faculty appointments in the Departments of Pharmacology, Psychiatry and Behavioral Sciences. He serves as interim executive associate dean for research in Emory School of Medicine. He is also a faculty member in the NS program.

An internationally recognized expert in neurodegenerative disorders, Levey's work has contributed to understanding the brain systems and mechanisms involved in disorders such as Alzheimer's and Parkinson's diseases, as well as in identifying molecular targets for new therapeutic strategies.

Levey's research interests include fundamental research into the cause of Alzheimer's disease and related neurodegenerative disorders and development of new biomarkers and treatments.

Click here to view the full story in the Emory News Center.